Top 2017 approved drugs U.S. revenue in 2024

Projected 2024 revenue for selected top drugs approved in the U.S. in 2018 (in million U.S. dollars)

Projected 2024 revenue for top drugs approved U.S. 2018

Last update:

Feb 14, 2019

Author:

��ƽ�� Research Department

Region:

United States

Survey time period:

From 01/01/2018 to 31/12/2024

This statistic displays the projected 2022 revenue for selected top drugs approved in the U.S. in 2018. Biktarvy, developed by Gilead Sciences, is estimated to generate some five billion U.S. dollars in annual revenue in 2024.

We’re happy to help

Get in touch with us for additional information

Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.

Get in touch

�����ƽ��

Projected 2024 revenue for selected top drugs approved in the U.S. in 2018 (in million U.S. dollars)

Get in touch with us for additional information

��ƽ��